Sato T, Suzuki Y, Taketani T, Ishiguro K, Nakajima H
J Clin Endocrinol Metab. 1977 Mar;44(3):553-9. doi: 10.1210/jcem-44-3-553.
Nine patients with athyrotic or ectopic cretinism ages 6 mo.-17 yrs-were studied to examine the relation between age and the quantities of oral L-thyroxine (T4) adequate to restore TSH hypersecretion to normal levels by feedback control. All but one patient had very low levels of endogenous T4 (below 1.0 mug/100 ml) before treatment. However, based on clinical signs and serum T4-1 values, all were judged to be euthyroid or sub-clinically hyperthyroid by L-T4 replacement during the observation period. L-T4 dosage was increased or decreased by 25 or 50 mug/day at 2-12 mo. intervals, and the TSH response to exogenous thyrotropin-releasing hormone (TRH) was tested sequentially at each dose of L-T4 until a normal or slightly suppressed TSH response was obtained The L-T4 dosage which was associated with normal TSH responsiveness to TRH (the adequate L-T4 dose) was high in infancy (10 mug/kg/day), decreasing with age to a level of 3-4 mug/kg/day in pubertal children (correlation coefficient r=-0.820, P less than 0.01). The adequate L-T4 dose observed between 4 and 12 yrs of age was lower than the usually recommended dose (4-6 vs. 7-8 mug/kg/day). On these L-T4 doses, serum T4I concentrations were significantly higher in patients under 5 yrs of age than in older patients (8.3+/-1.5 vs. 6.5+/-0.7 mug/100 ml, P less than 0.02). Serum triiodothyronine (T3) values were also elevated in young children, decreasing with age to the normal range. TSH responses to TRH were completely suppressed at the serum T4-I levels of 9 mug/100 ml and T3 of 250 ng/100 ml or less in 7 patients over 4 yrs of age, but not in 2 younger patients. Although the number of patients examined was limited, these results suggest that the pituitary threshold for feedback regulation of TSH secretion by T4 decreases with age in children with cretinism and the usually recommended replacement doses of L-T4 between 4 and 12 yrs of age are probably overestimated.
对9例年龄在6个月至17岁的甲状腺发育不全或异位克汀病患者进行了研究,以探讨年龄与口服左旋甲状腺素(T4)量之间的关系,该剂量的左旋甲状腺素足以通过反馈控制使促甲状腺激素(TSH)分泌亢进恢复到正常水平。除1例患者外,所有患者在治疗前内源性T4水平都非常低(低于1.0μg/100ml)。然而,根据临床体征和血清T4-I值,在观察期内通过左旋甲状腺素替代治疗,所有患者均被判定为甲状腺功能正常或亚临床甲状腺功能亢进。左旋甲状腺素剂量每隔2至12个月增加或减少25或50μg/天,并在每次左旋甲状腺素剂量时依次检测TSH对外源性促甲状腺激素释放激素(TRH)的反应,直到获得正常或轻微受抑制的TSH反应。与TSH对TRH的正常反应性相关的左旋甲状腺素剂量(合适的左旋甲状腺素剂量)在婴儿期较高(10μg/kg/天),随着年龄增长而降低,在青春期儿童中降至3至4μg/kg/天的水平(相关系数r = -0.820,P<0.01)。4至12岁患者观察到的合适左旋甲状腺素剂量低于通常推荐的剂量(4至6μg/kg/天对7至8μg/kg/天)。在这些左旋甲状腺素剂量下,5岁以下患者的血清T4I浓度显著高于年龄较大的患者(8.3±1.5μg/100ml对6.5±0.7μg/100ml,P<0.02)。幼儿的血清三碘甲状腺原氨酸(T3)值也升高,随着年龄增长降至正常范围。4岁以上的7例患者中,当血清T4-I水平为9μg/100ml且T3为250ng/100ml或更低时,TSH对TRH的反应被完全抑制,但2例年龄较小的患者未出现这种情况。尽管所检查的患者数量有限,但这些结果表明,克汀病患儿中T4对TSH分泌的反馈调节的垂体阈值随年龄降低,4至12岁通常推荐的左旋甲状腺素替代剂量可能被高估了。